0000899243-22-003573.txt : 20220128
0000899243-22-003573.hdr.sgml : 20220128
20220128175357
ACCESSION NUMBER: 0000899243-22-003573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220126
FILED AS OF DATE: 20220128
DATE AS OF CHANGE: 20220128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hunt Hazel
CENTRAL INDEX KEY: 0001698307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 22570493
MAIL ADDRESS:
STREET 1: C/O CORCEPT THERAPEUTICS INCORPORATED
STREET 2: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-26
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001698307
Hunt Hazel
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
Chief Scientific Officer
Common Stock
2022-01-26
4
M
0
40000
3.32
A
78493
D
Common Stock
2022-01-26
4
F
0
25350
17.16
D
53143
D
Stock Option (Right to Buy)
3.32
2022-01-26
4
M
0
40000
0.00
D
2022-02-01
Common Stock
40000
0
D
These shares were withheld so the Reporting Person could satisfy the exercise price and the withholding of taxes arising from a net (cashless) exercise of stock options. The options subject to the net exercise were to expire on February 1, 2022.
Fully exercisable.
/s/ Joseph Douglas Lyon, Attorney-in-Fact for Hazel Hunt
2022-01-28